NCT04281797 is a clinical trial of Intestinal microbiome new generation sequencing in Transplantation Infection, sponsored by Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology.

What drugs are being tested in NCT04281797?

Interventions in NCT04281797: Intestinal microbiome new generation sequencing.

What condition does NCT04281797 study?

NCT04281797 studies Transplantation Infection, Kidney Transplant; Complications, Stem Cell Transplant Complications, Liver Transplant; Complications, Microbial Colonization.

Is NCT04281797 still recruiting?

NCT04281797 is currently status unknown. Last updated 31 August 2022.

Last reviewed 2022-08-31 · How we verify

NCT04281797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Status unknown Last updated 31 August 2022

What this trial tests

trial testing Intestinal microbiome new generation sequencing in Transplantation Infection in 90 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
31 December 2022

30 June 2023

Quick facts

Lead sponsor	Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 January 2020
Primary completion	31 December 2022
Estimated completion	30 June 2023
Sites	1 location across Belarus

Drugs / interventions tested

Intestinal microbiome new generation sequencing

Conditions studied

Transplantation Infection — all drugs for Transplantation Infection →
Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
Stem Cell Transplant Complications — all drugs for Stem Cell Transplant Complications →
Liver Transplant; Complications — all drugs for Liver Transplant; Complications →

Sponsor

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology — full company profile →

Who can join

Eligibility, any sex, with Transplantation Infection or Kidney Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot study designed to investigate the alterations in the gut microbiome that occur during the course of kidney transplantation, liver transplantation, allogeneic hematopoietic stem cells and mesenchymal stem cells transplantation in association with the clinical outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation.
Yu J, Sun H, Cao W, Han L, et al · · 2020 · cited 19× · PMID 33292670 · DOI 10.1186/s40164-020-00194-y

Verify or expand the search:

Other recruiting trials for Transplantation Infection

Currently open trials in the same condition.

NCT05947071 — High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients · Phase 2 · recruiting
NCT05215327 — High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients · Phase 2 · recruiting
NCT05198570 — Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients · recruiting
NCT04613206 — High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients · Phase 2 · active not recruiting
NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting

Other Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology trials

Trials by the same sponsor.

NCT07477912 — Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma · Phase 1, PHASE2 · recruiting
NCT03619252 — Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04281797 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Last refreshed: 31 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04281797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing